Immunosuppressant combination therapy

This page covers all Immunosuppressant combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting mTOR (sirolimus component); IMPDH (mycophenolate component being replaced).

Targets

mTOR (sirolimus component); IMPDH (mycophenolate component being replaced)

Marketed (1)

• Mycophenolate to sirolimus switch · London Health Sciences Centre · Immunology / Transplantation
  A therapeutic strategy that replaces mycophenolate mofetil with sirolimus to reduce immunosuppressive burden while maintaining graft protection in transplant recipients.

Patent intelligence

• immunosuppressant combination therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates